Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-06-21

Clinical Trial Update: Efficacy and Safety Study to Evaluate Combination Therapy With Nebivolol and Lisinopril vs. Placebo and Monotherapy in Patients With Stage 2 Diastolic Hypertension [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated the efficacy and safety of combining nebivolol with lisinopril versus placebo and monotherapy in patients with hypertension; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lisinopril (Lisinopril)
  • Nebivolol (Bystolic) (nebivolol)

Snippet

Sponsor: Forest Laboratories | Conditions: Stage 2 Diastolic Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2012-06-21